Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only Get Premium

PMVP PMV Pharmaceuticals Inc

Price (delayed)

$0.95

Market cap

$49.36M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.18

Enterprise value

-$879,954

PMV Pharma is a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53 mutants. p53 mutations are found in approximately half of all cancers. ...

Highlights
The debt has dropped by 92% year-on-year and by 7% since the previous quarter
The quick ratio is up by 39% QoQ
The EPS is up by 11% year-on-year but it has declined by 3.5% since the previous quarter
The company's net income rose by 6% YoY but it fell by 3.7% QoQ
PMVP's equity is down by 25% year-on-year and by 9% since the previous quarter

Key stats

What are the main financial stats of PMVP
Market
Shares outstanding
51.95M
Market cap
$49.36M
Enterprise value
-$879,954
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.31
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
Gross profit
$0
Operating income
-$88.79M
Net income
-$60.88M
EBIT
-$79.17M
EBITDA
-$78.6M
Free cash flow
-$53.18M
Per share
EPS
-$1.18
EPS diluted
-$1.18
Free cash flow per share
-$1.02
Book value per share
$3.08
Revenue per share
$0
TBVPS
$3.28
Balance sheet
Total assets
$170.61M
Total liabilities
$10.5M
Debt
$1.11M
Equity
$160.11M
Working capital
$153.74M
Liquidity
Debt to equity
0.01
Current ratio
16.75
Quick ratio
16.43
Net debt/EBITDA
0.64
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-29.6%
Return on equity
-32.5%
Return on invested capital
-51.8%
Return on capital employed
-49.2%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

PMVP stock price

How has the PMV Pharmaceuticals stock price performed over time
Intraday
2.15%
1 week
6.1%
1 month
1.18%
1 year
-45.09%
YTD
-37.09%
QTD
-12.84%

Financial performance

How have PMV Pharmaceuticals's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$88.79M
Net income
-$60.88M
Gross margin
N/A
Net margin
N/A

PMVP financials

PMVP's operating income is down by 16% YoY and by 3.9% from the previous quarter
The company's net income rose by 6% YoY but it fell by 3.7% QoQ

Price vs fundamentals

How does PMVP's price correlate with its fundamentals

PMVP Price vs fundamentals

PMVP Earnings waterfall

PMVP Price vs fair value

Growth

What is PMV Pharmaceuticals's growth rate over time

PMVP growth chart

Valuation

What is PMV Pharmaceuticals stock price valuation
P/E
N/A
P/B
0.31
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A

Valuation vs average

Price to earnings (P/E)

The EPS is up by 11% year-on-year but it has declined by 3.5% since the previous quarter

Price to book (P/B)

PMVP's price to book (P/B) is 87% less than its 5-year quarterly average of 2.3 and 23% less than its last 4 quarters average of 0.4
PMVP's equity is down by 25% year-on-year and by 9% since the previous quarter

Price to sales (P/S)

Efficiency

How efficient is PMV Pharmaceuticals business performance
PMV Pharmaceuticals's ROIC has plunged by 56% YoY and by 19% from the previous quarter
The return on assets has declined by 13% year-on-year and by 12% since the previous quarter
The company's return on equity fell by 12% YoY and by 11% QoQ

Dividends

What is PMVP's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for PMVP.

Financial health

How did PMV Pharmaceuticals financials performed over time

Assets vs liabilities

The total liabilities has dropped by 57% year-on-year and by 31% since the previous quarter
The quick ratio is up by 39% QoQ

Debt vs equity

The debt is 99% smaller than the equity
The debt has dropped by 92% year-on-year and by 7% since the previous quarter
The company's debt to equity has shrunk by 83% YoY

Balance sheet

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.